Gal-3 for MACEs in patients with DCM was reported in seven studies (Binas et al., 2018; Hu et al., 2016; Karatolios et al., 2018; Revnic et al., 2022; Rubiś et al., 2021; Vergaro et al., 2015; Wojciechowska et al., 2017) that included 945 patients. The gene discussed is LGALS3; the disease is familial dilated cardiomyopathy.